Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Laser treatment can stimulate hair growth for male pattern hair loss.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Early intervention and tailored management can reduce skin side effects from cancer treatments.